XML 19 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash and cash equivalents $ 3,524,308 $ 11,367,034
Short-term investments 4,140,880
Equity investments 3,118
Prepaid expenses and other current assets 15,970 135,894
Note receivable, including interest receivable of $9,600 and $6,010 at December 31, 2023 and 2022, respectively 66,010
Total Current Assets 7,681,158 11,572,056
Prepaid expenses and other assets - non-current 64,983 70,821
Total Assets 7,746,141 11,642,877
CURRENT LIABILITIES:    
Accounts payable and accrued expenses 703,488 364,216
Deferred revenue - current portion 72,102 72,102
Total Current Liabilities 775,590 436,318
LONG TERM LIABILITIES:    
Deferred revenue - long-term portion 793,680 865,782
Total Long Term Liabilities 793,680 865,782
Total Liabilities 1,569,270 1,302,100
Commitment and Contingencies (see Note 8)
STOCKHOLDERS’ EQUITY:    
Preferred stock, $0.0001 par value, 5,000,000 shares authorized: none designated as of December 31, 2023 Common stock, $0.0001 par value, 100,000,000 shares authorized; 3,159,096 and 3,158,797 shares issued and 2,906,241 and 3,158,797 shares outstanding at December 31, 2023 and 2022, respectively 316 316
Additional paid-in capital 17,525,714 17,511,589
Treasury stock, at cost (252,855 and 0 shares on December 31, 2023 and 2022, respectively) (471,121)
Accumulated other comprehensive loss (6,227)
Accumulated deficit (10,871,811) (7,171,128)
Total Stockholders’ Equity 6,176,871 10,340,777
Total Liabilities and Stockholders’ Equity $ 7,746,141 $ 11,642,877